. Author manuscript; available in PMC: 2022 Jul 21.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Nov 9;20(3):e131–e136. doi: 10.1016/j.clml.2019.11.001

Table 2:

Outcome in acute myeloid leukemia patients based on body mass index

	BMI <25^*	BMI 25-30	BMI ≥30	p-value
CR/CRi after initial chemotherapy (n,%)	34 (39.1)	41 (38.7)	45 (37.5)	0.6
HCT performed (n, %)	29 (33.3)	33 (32)	29 (24.8)	0.6
Cause of death (n, %)				0.5
• AML	37 (49.3)	58 (59.2)	60 (57.7)
• Treatment complications	10 (13.3)	14 (14.3)	12 (11.5)
• Others	1 (1.3)	2 (2)	5 (4.8)
AML in remission at the time of death (n, %)	13 (15.5)	11 (10.9)	22 (19.5)	0.3

One patient had BMI <18.5, AML- Acute myeloid leukemia, BMI- Body mass index, CR- Complete remission CRi- Complete remission with incomplete hematological response.